The weekly litigation news digest is live. Subscribe now

IP Verse

Producing Hybrid Antibodies Containing Human Variable Regions And Rodent Constant Regions - EP3085780

The patent EP3085780 was granted to Regeneron Pharmaceuticals on Jun 28, 2023. The application was filed on Feb 15, 2002 under application number EP16171561A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3085780

REGENERON PHARMACEUTICALS
Application Number
EP16171561A
Filing Date
Feb 15, 2002
Status
Patent Maintained As Amended
May 26, 2023
Publication Date
Jun 28, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
KYMABJun 28, 2019CMS CAMERON MCKENNA NABARRO OLSWANGWITHDRAWN

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5350689
DESCRIPTIONUS5436149
DESCRIPTIONUS5508189
DESCRIPTIONUS5770429
DESCRIPTIONUS5789215
OPPOSITIONEP1399575
OPPOSITIONWO2012148873
OPPOSITIONWO2015088643
SEARCHUS5939598
SEARCHWO9945962

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents